BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21059423)

  • 1. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
    Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
    Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntax score predicts clinical outcome in patients with three-vessel coronary artery disease undergoing percutaneous coronary intervention.
    He JQ; Gao YC; Yu XP; Zhang XL; Luo YW; Wu CY; Li Y; Zhang WD; Chen F; Lü SZ
    Chin Med J (Engl); 2011 Mar; 124(5):704-9. PubMed ID: 21518562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
    Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
    Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
    Mack MJ; Banning AP; Serruys PW; Morice MC; Taeymans Y; Van Nooten G; Possati G; Crea F; Hood KL; Leadley K; Dawkins KD; Kappetein AP
    Ann Thorac Surg; 2011 Dec; 92(6):2140-6. PubMed ID: 21967819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.